449 related articles for article (PubMed ID: 31880232)
21. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management.
Schultz BG; Tilton J; Jun J; Scott-Horton T; Quach D; Touchette DR
Value Health; 2021 Apr; 24(4):522-529. PubMed ID: 33840430
[TBL] [Abstract][Full Text] [Related]
22. Development of a Pharmacoeconomic Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes Management.
Ourth H; Nelson J; Spoutz P; Morreale AP
J Manag Care Spec Pharm; 2018 May; 24(5):449-457. PubMed ID: 29694293
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
24. Economic and utilization outcomes of medication management at a large Medicaid plan with disease management pharmacists using a novel artificial intelligence platform from 2018 to 2019: a retrospective observational study using regression methods.
Kessler S; Desai M; McConnell W; Jai EM; Mebine P; Nguyen J; Kiroyan C; Ho D; Von Schweber E; Von Schweber L
J Manag Care Spec Pharm; 2021 Sep; 27(9):1186-1196. PubMed ID: 34032130
[No Abstract] [Full Text] [Related]
25. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
26. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations.
Newman TV; Hernandez I; Keyser D; San-Juan-Rodriguez A; Swart ECS; Shrank WH; Parekh N
J Manag Care Spec Pharm; 2019 Sep; 25(9):995-1000. PubMed ID: 31456493
[TBL] [Abstract][Full Text] [Related]
27. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
[TBL] [Abstract][Full Text] [Related]
28. Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program.
Ni W; Colayco D; Hashimoto J; Komoto K; Gowda C; Wearda B; McCombs J
J Manag Care Spec Pharm; 2018 Feb; 24(2):90-96. PubMed ID: 29384028
[TBL] [Abstract][Full Text] [Related]
29. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
Trapskin K; Johnson C; Cory P; Sorum S; Decker C
J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
[TBL] [Abstract][Full Text] [Related]
30. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
31. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
[TBL] [Abstract][Full Text] [Related]
32. Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings.
Bishop MA; Chang HY; Kitchen C; Weiner JP; Kharrazi H; Shermock KM
J Manag Care Spec Pharm; 2021 Aug; 27(8):1009-1018. PubMed ID: 34337988
[No Abstract] [Full Text] [Related]
33. Dispelling the myths about medication therapy management services.
Martin CM; McSpadden CS
Consult Pharm; 2008 Nov; 23(11):866-72, 875. PubMed ID: 19072011
[TBL] [Abstract][Full Text] [Related]
34. A sustainable business model for comprehensive medication management in a patient-centered medical home.
Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
36. Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.
Coe AB; Choe HM; Diez HL; Rockey NG; Ashjian EJ; Dorsch MP; Kim HM; Farris KB
J Manag Care Spec Pharm; 2020 Dec; 26(12):1558-1566. PubMed ID: 33251995
[No Abstract] [Full Text] [Related]
37. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions.
McFarland MS; Thomas AM; Young E; Bryant C; Hughes JC; Hoffman J; Baker JW
J Manag Care Spec Pharm; 2020 Apr; 26(4):513-519. PubMed ID: 32223605
[TBL] [Abstract][Full Text] [Related]
38. Effect of an Advanced Pharmacy Practice Experience on Medication Therapy Management Services in a Centralized Retail Pharmacy Program.
Vande Griend JP; Rodgers M; Nuffer W
J Manag Care Spec Pharm; 2017 May; 23(5):561-565. PubMed ID: 28448777
[TBL] [Abstract][Full Text] [Related]
39. Improving population management through pharmacist-primary care integration: a pilot study.
Kennedy AG; Chen H; Corriveau M; MacLean CD
Popul Health Manag; 2015 Feb; 18(1):23-9. PubMed ID: 25029631
[TBL] [Abstract][Full Text] [Related]
40. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
Scott MA; Hitch WJ; Wilson CG; Lugo AM
J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
